The proteome of normal pancreatic juice
- PMID: 22129531
- PMCID: PMC3288545
- DOI: 10.1097/MPA.0b013e31822862f6
The proteome of normal pancreatic juice
Abstract
Objectives: The aims of this study were to characterize the proteome of normal pancreatic juice, to analyze the effect of secretin on the normal proteome, and to compare these results with published data from patients with pancreatic cancer.
Methods: Paired pancreatic fluid specimens (before and after intravenous secretin stimulation) were obtained during endoscopic pancreatography from 3 patients without significant pancreatic pathology. Proteins were identified and quantified by mass spectrometry-based protein quantification technology. The human RefSeq (NCBI) database was used to compare the data in samples from patients without pancreatic disease with published data from 3 patients with pancreatic cancer.
Results: A total of 285 proteins were identified in normal pancreatic juice. Ninety had sufficient amino acid sequences identified to characterize the protein with a high level of confidence. All 90 proteins were present before and after secretin administration but with altered relative concentrations, usually by 1 to 2 folds, after stimulation. Comparison with 170 published pancreatic cancer proteins yielded an overlap of only 42 proteins.
Conclusions: Normal pancreatic juice contains multiple proteins related to many biological processes. Secretin alters the concentration but not the spectrum of these proteins. The pancreatic juice proteome of patients without pancreatic disease and that of patients with pancreatic cancer differ markedly.
Figures

References
-
- Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. Fourth ed. Garland Science; New York, NY: 2002.
-
- Baak JP, Mohan H, Baak JPA, et al. Genomics and proteomics in neoplasia. Indian J Pathol Microbiol. 2007 Jan;50(1):1–5. - PubMed
-
- Cazares LH, Diaz JI, Drake RR, et al. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers. Methods Mol Biol. 2008;428:125–140. - PubMed
-
- Cho WC, Cheng CH, Cho WCS, et al. Oncoproteomics: current trends and future perspectives. Expert Rev Proteomics. 2007 Jun;4(3):401–410. - PubMed
-
- Dhamoon AS, Kohn EC, Azad NS, et al. The ongoing evolution of proteomics in malignancy. Drug Discov Today. 2007 Sep;12(17-18):700–708. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical